The anti-osteoporosis effects have been attributed to arecoline, which has been shown to inhibit the downstream transcription factors nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases activated by RANKL–RANK interactions [16,24]. This evidence concerns the gene TNFRSF11A and osteoporosis.